Your browser doesn't support javascript.
loading
Multicenter phase II study of SOX plus trastuzumab for patients with HER2+ metastatic or recurrent gastric cancer: KSCC/HGCSG/CCOG/PerSeUS 1501B.
Yuki, Satoshi; Shinozaki, Katsunori; Kashiwada, Tomomi; Kusumoto, Tetsuya; Iwatsuki, Masaaki; Satake, Hironaga; Kobayashi, Kazuma; Esaki, Taito; Nakashima, Yuichiro; Kawanaka, Hirofumi; Emi, Yasunori; Komatsu, Yoshito; Shimokawa, Mototsugu; Makiyama, Akitaka; Saeki, Hiroshi; Oki, Eiji; Baba, Hideo; Mori, Masaki.
Afiliação
  • Yuki S; Department of Gastroenterology and Hepatology, Hokkaido University Hospital, Sapporo, Japan.
  • Shinozaki K; Division of Clinical Oncology, Hiroshima Prefectural Hospital, Hiroshima, Japan.
  • Kashiwada T; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan.
  • Kusumoto T; Department of Gastroenterological Surgery/Clinical Research Institute Cancer Research Division, National Kyushu Medical Center, Fukuoka, Japan.
  • Iwatsuki M; Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
  • Satake H; Department of Medical Oncology, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Kobayashi K; Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Esaki T; Department of Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
  • Nakashima Y; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
  • Kawanaka H; Department of Gastroenterological Surgery, Clinical Research Institute, National Hospital Organization Beppu Medical Center, Beppu, Japan.
  • Emi Y; Department of Surgery, Saiseikai Fukuoka General Hospital, Fukuoka, Japan.
  • Komatsu Y; Division of Cancer Center, Hokkaido University Hospital, Sapporo, Japan.
  • Shimokawa M; Yamaguchi University, Ube, Japan.
  • Makiyama A; Department of Hematology/Oncology, Japan Community Health Care Organization, Kyushu Hospital, Kitakyushu, Japan.
  • Saeki H; Department of General Surgical Science, Graduate School of Medicine, Gunma University, Maebashi, Japan.
  • Oki E; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan. okieiji@surg2.med.kyushu-u.ac.jp.
  • Baba H; Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
  • Mori M; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
Cancer Chemother Pharmacol ; 85(1): 217-223, 2020 01.
Article em En | MEDLINE | ID: mdl-31768696
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Protocolos de Quimioterapia Combinada Antineoplásica / Receptor ErbB-2 / Neoplasias Hepáticas / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Chemother Pharmacol Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Protocolos de Quimioterapia Combinada Antineoplásica / Receptor ErbB-2 / Neoplasias Hepáticas / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Chemother Pharmacol Ano de publicação: 2020 Tipo de documento: Article